{"name":"Carrick Therapeutics Limited","slug":"carrick-therapeutics-limited","ticker":"","exchange":"","domain":"carrick.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxQYk14b3NXejlUVDJkbUN0OEhMR0pCSDFDa3pzYVZCYkxHNG9mUmJLSVZ5OUZTeVVKYUpaR3FnWmxvWGlzUWZRVHFpR3NXTHNEa2N6SkcyVGlfb3hLeGp5dFkyQzI2N1dmNXp5ZzRUbWFKWWxqQmNYMUZKUWo1dml3ZUMwQjB3cXJNMzI0ZldLOTFmS0lpb0o1X0RjazMxemg5dDQwZFk1S1lKMzVMRTRCSnN6NkNDa2xIMTNmRUtHNV8tZzh1Q3AySGo1Ym1aTnJoeVh1STVnLTBxYlROSmNHQnc0LVBCUQ?oc=5","date":"2026-03-27","type":"pipeline","source":"Barchart.com","summary":"Pancreatic Cancer Treatment Pipeline Shows Strong Momentum as 170+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Pancreatic Cancer Treatment Pipeline Shows Strong Momentum as 170+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxOSEJpa0ZlcDJDNElMWTRmUjBhWVBXVGNCTDhmWExfRjZzd1V3M0xMTEtkakp0TW4xN0M1SXgtc1FDTjlzeVhKMi1rRk9EdEJpaWVpX2dReU1zOVdva2I5eU1OZ2pyc3hyaDVrTWVpWTFYWDEyNm04Tmg1dFdFcmRwVm55STJ4bUVXMG9ZVFFRQlN0ZEVsb2xxVmZqWDFzc1RlWVRlMkxNUFhRRlJDaVRuLTdaclY1bFY3Vmh6TlpabXJrVXFQbmhCNkI2WVdzVkJyQkF5T3pBUFBqY2c5RkxPcmJkRHlZX1IxdU1YTE1VMmtWbVpRODlyZHVxNnZDcmNNWXJ0NDBianBCNU9YY1ZB?oc=5","date":"2026-02-10","type":"regulatory","source":"PR Newswire UK","summary":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | DelveInsight - PR Newswire UK","headline":"PROTAC Market Shows Accelerated Growth During the Forecast Period (2025-2034) Amid Rising Targeted Therapy Demand | Delv","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE4xMHVKU1RITHdrZjVaUW1md05BUnU3UzhLMG82YXJHUWtDYnpMTDFEU051UjVWVlFDLTcyb3dpQTZQcTVnempQbmM0ekhjeVBPVlp2NDJyMHl1QllIR3ZF?oc=5","date":"2026-01-13","type":"trial","source":"Nature","summary":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson - Nature","headline":"Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWlRlSV9PSnA1QU5GQ1d4N2VyZWxoTllPRXFrVGJOTEppbW80WnlQRVFMUWpSQjJuaExDcnpvRTVSTnhTRVhXZUVKclhIYmVILWNVN0EyYjBwM3YxaFRqLUZqTlRPVmZiR0tmUnFNcXFBcTRkczR1Q0tRY24zcEFsa3BDaktVWFFxbFE?oc=5","date":"2025-12-12","type":"trial","source":"Oncology Pipeline","summary":"SABCS 2025 – Carrick sees a way forward in CDK7 | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline","headline":"SABCS 2025 – Carrick sees a way forward in CDK7 | ApexOnco - Clinical Trials news and analysis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOak0zX2xwakFIazJIekRtd1Z3a20xckg2ZjNhUjBLSnlFY0xHbkZITWtnUlNIa0QyQW5iS044X21qaUM3aWVzajRnQ1RFdzNoQnR2N0U4Qm80Wk9oWEsxZ0YtYWpIRHN3SXFUUU16N0tyaVNHYmZCWUZuQ0NZUXhfMFJJQkhQQmNOSk1RdUc5VUFNcEVXSHVhWElCR3NaTHRtNFo1VnFRTXJWYkx2VDRxdGxTRnlBQQ?oc=5","date":"2025-10-23","type":"pipeline","source":"seekingalpha.com","summary":"Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX) - seekingalpha.com","headline":"Recursion Pharmaceuticals: Premium Valuation Without Proof (Rating Downgrade) (NASDAQ:RXRX)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AJBVV95cUxOZnJsMHk1SkVHdTRkc1pqTHdYUkpSRnlVS0ZOSjNGbjd6U2lKdWRJV0ZaV0FIdEVpYXhBdW41V3FSczlrNkpiYzZPN216ZWFsMUNfZ2F6NXVwNTQwSDNiWHlCbWExYjZCV3IwVU5MRXBnNjJ1NG1LdnVuTVJfVUJLRE1tc3ZwMnI3NlVqZ0gxa1BnanJ2em9BTmdlTm8xb2pHRVpiTm9zVzVpeWhhemY4VHZ0R3ZpdGdxMUtCTlpVaHBqenFScGV0Z3BGZ2hUdGdHMjBhMkh6XzZCZTNtNHBwR1BzY1R6aGx3S000eXdvMERBWFlQaGdTNFR6WHJSOHRQOG5qSEhvcTBPaG9kSHk2NHdIUk9VaW9GSzhPanltUjZKcmtFVm5wNVBjWERrR2VOUE45Ri1GX2UyNS1PdjRJUnVoOUV3QUhGU1VRdFkyNzRMeUxIeEZMQmlLSVRYWFgxUlpmb0hjaUc0WWFH?oc=5","date":"2025-05-15","type":"trial","source":"GlobeNewswire","summary":"Carrick Therapeutics Announces New Clinical Data Supporting - GlobeNewswire","headline":"Carrick Therapeutics Announces New Clinical Data Supporting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNTjZGNEtXNVFxV0FucWNPSUlNMTF5XzNGZWctT2ZGMWpwT25XMURfLU1TcmRTc0s1eXNQQUdVOVRfaXppcVg3YV8wYzE1ZVZVY2toUElYakNMSHB5cXhsVTNzeGhCYVM0ckFybG1IbjRJTUtHazVHQ3BPQ0tTM0U2S0NtYzJrdGxDN1RoRQ?oc=5","date":"2025-05-12","type":"pipeline","source":"The ASCO Post","summary":"In Case You Missed It: Additional Abstracts of Interest From AACR - The ASCO Post","headline":"In Case You Missed It: Additional Abstracts of Interest From AACR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwJBVV95cUxOdVlhOFhDYnpBRGh4WlhFWG93ZHdmak5FZDVRVC1qWER1YlFhbnQ5TThBM0Y5ZjJaaExucGI2LVNsSmRUMDQ3cVBHT211N1JHVXNBRklDUTR1VjdITWkxSTA5OXNTMkZ2S3hnVDBMNHJYamp2Ri1UcHhBRlBLUWNxLXFMeHRlXzFpOXpkRzF4NlZWYlBGS0xqaGlHSlMzMkRFcG1tRjd4aU5sOE5TUWJvdklNd0F5YmZIMU91Tng5X0F3UlJESVI1M0tDaUFid2c1MjlhMlFiTHNGaUViTkN3b01pM2J4cndGY0NueG9VTTl0bGtmWF9KcEpZOVlodHZQWE5FbW1aNDBzTTNZTVNWTWpWZjhVM00zcHZIUV9sTQ?oc=5","date":"2025-01-14","type":"trial","source":"PR Newswire","summary":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Development | DelveInsight - PR Newswire","headline":"Non-Small Cell Lung Cancer Clinical Trial Pipeline Boom as Over 100 Companies Leading the Charge in Research and Develop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxNZ1R2OG0yX293dnl5YVhwS3UtcmtBQ0wzaFFFMVZBcVA0TmFZQnFJUXNKYjBNVEJoMkE1dlFjcXRVRTNhSk8tLUgzZjl3MkJMZFJIOTV4QzdhVWJMUmtqZXQwai1QLXVqNk50cUF4TkJtaDlUOHdkaUFtM3Ixak4tYm5JRjl5VHVJaHloSFFYN25RTkM5S2NvOWlIT250bDA5MEloU2phQm5TZklCdEFzQ2c3ZGdfWHF0eThURTMyOW1LSXRzVGpOaENhWFBzVHNyRzlEamp1RU96bW5vZWc0?oc=5","date":"2024-09-25","type":"pipeline","source":"PR Newswire","summary":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight - PR Newswire","headline":"CDK 7 Inhibitors Market is Expected to Showcase a Significant Growth by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQeGxLVlZIbW1OdFo1cXZPM2ZsdC1CazBxMXpfcWRqYmdQbEs5TmpyaWV6TWNkRXRGSUxNcnUzbGtBOGFESEdYQ01UbzhYbWdNWkFsV25id0JwMWhodGU5S1RfMU5xU2hsTnN4Mmk3S2J3dUJNc1V4UzJvOUxBejcyTGV4STJIekZTRWo0dm1MckRmaUZQZXJUTUhVclV3RllONjRpN0FBRnZEX3NfT1dPS3NvekJJRFBCd0t3OTRnYktPcGppNXFuMFkxa1pNdEQtVnNYdHN1bVdtNksycUpsczZfVkdHdXI1TDRGc2tpNnhFcVNlMHBVYkJqMmhnQ1FTM2pVLUloeXg?oc=5","date":"2024-09-23","type":"trial","source":"GlobeNewswire","summary":"Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor) - GlobeNewswire","headline":"Carrick Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT7439 (CDK12/13 Inhibitor)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNS0xJRzdqU1hkaEV3c1BzZHd3V1BvUjFoLWo3aW80SktGMWdNaFBJYkViTE9YbkNxcy03WjNTTU1XbTlVMkdHWWdmeXJobFZIcnVVZ1BlcVJPX2VWenhyV2J4dFdodTBWcDZOTklYNDBvMXpURnZMQnhLa2d5WmcwWkRoTU53Nnd4aGFsY1c2MTU0SmZrUDhQeU14VkRMeXRNdW5nVU9Xal9Sd1JFZGRlMU5CMzNNTGlZSGJuUzhvWQ?oc=5","date":"2024-05-10","type":"trial","source":"The ASCO Post","summary":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer - The ASCO Post","headline":"Selective Targeting of PARP1 in Early-Phase Study Shows Activity in Breast Cancer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}